Document is current
Any future updates will be listed below
-
Authors
Anbil, Sriram
Reiss, Kim A.
- License Information
-
More Information
Article History
Accepted: 22 December 2023
First Online: 4 January 2024
Compliance with Ethical Standards
:
: Sriram Anbil declares no competing interests. Kim A. Reiss has served as a consultant/advisory board member for AstraZeneca, Bristol Myers Squibb, and Foundation Medicine.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
